Lindbrook Capital’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-544
| Closed | -$1.78K | – | 2759 |
|
|
2024
Q1 | $1.78K | Hold |
544
| – | – | ﹤0.01% | 2283 |
|
|
2023
Q4 | $1.91K | Sell |
544
-234
| -30% | -$821 | ﹤0.01% | 2278 |
|
|
2023
Q3 | $5.2K | Hold |
778
| – | – | ﹤0.01% | 1744 |
|
|
2023
Q2 | $6.53K | Buy |
778
+417
| +116% | +$3.5K | ﹤0.01% | 1681 |
|
|
2023
Q1 | $3.59K | Sell |
361
-151
| -29% | -$1.5K | ﹤0.01% | 1998 |
|
|
2022
Q4 | $3.56K | Sell |
512
-249
| -33% | -$1.73K | ﹤0.01% | 1977 |
|
|
2022
Q3 | $4K | Hold |
761
| – | – | ﹤0.01% | 1722 |
|
|
2022
Q2 | $3K | Hold |
761
| – | – | ﹤0.01% | 1732 |
|
|
2022
Q1 | $3K | Sell |
761
-1,780
| -70% | -$7.02K | ﹤0.01% | 1774 |
|
|
2021
Q4 | $10K | Buy |
+2,541
| New | +$10K | ﹤0.01% | 1250 |
|
|
2019
Q4 | – | Sell |
-3,000
| Closed | -$16K | – | 1495 |
|
|
2019
Q3 | $16K | Hold |
3,000
| – | – | 0.01% | 773 |
|
|
2019
Q2 | $18K | Buy |
+3,000
| New | +$18K | 0.01% | 728 |
|